EP 4251154 A1 20231004 - SUSTAINED RELEASE FORMULATION COMPOSITIONS COMPRISING PROPIVERINE
Title (en)
SUSTAINED RELEASE FORMULATION COMPOSITIONS COMPRISING PROPIVERINE
Title (de)
PROPIVERIN ENTHALTENDE FORMULIERUNGSZUSAMMENSETZUNGEN MIT VERZÖGERTER FREISETZUNG
Title (fr)
COMPOSITIONS DE FORMULATION À LIBÉRATION PROLONGÉE COMPRENANT DE LA PROPIVÉRINE
Publication
Application
Priority
TR 2020051189 W 20201127
Abstract (en)
[origin: WO2022115056A1] The present invention relates to a novel sustained release solid pharmaceutical composition for oral administration comprising propiverine or a pharmaceutically acceptable salt thereof with at least one pH independent release controlling polymer for use in the treatment of urinary urgency, frequency and urge incontinence, all symptoms of overactive bladder syndrome.
IPC 8 full level
A61K 31/445 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/22 (2006.01); A61K 9/50 (2006.01); A61K 47/38 (2006.01); A61P 13/00 (2006.01); A61P 13/10 (2006.01)
CPC (source: EP)
A61K 9/1652 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 31/445 (2013.01); A61P 13/00 (2018.01); A61P 13/10 (2018.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DOCDB simple family (application)
TR 2020051189 W 20201127; EP 20963798 A 20201127